N N Bock1, R M Sales, T Rogers, B DeVoe. 1. Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia 30303, USA. neb2@cdc.gov
Abstract
OBJECTIVE: To determine whether incentives increase adherence to directly observed therapy (DOT) for tuberculosis (TB) treatment. METHODS: The TB program gave a five-dollar grocery coupon for each DOT appointment kept to 55 patients who had missed at least 25% of DOT doses over a 4-week period. Treatment completion rates were compared with an historic control group of 52 patients who began treatment a year earlier, who would have been eligible for incentives but did not receive them. RESULTS: Incentive program patients were more likely than control patients to complete therapy within 32 weeks (OR 5.73, 95%CI 2.25-14.84) and 52 weeks (OR 7.29, 95%CI 2.45-22.73). CONCLUSION: Patient incentives can increase adherence to DOT in TB programs.
OBJECTIVE: To determine whether incentives increase adherence to directly observed therapy (DOT) for tuberculosis (TB) treatment. METHODS: The TB program gave a five-dollar grocery coupon for each DOT appointment kept to 55 patients who had missed at least 25% of DOT doses over a 4-week period. Treatment completion rates were compared with an historic control group of 52 patients who began treatment a year earlier, who would have been eligible for incentives but did not receive them. RESULTS: Incentive program patients were more likely than control patients to complete therapy within 32 weeks (OR 5.73, 95%CI 2.25-14.84) and 52 weeks (OR 7.29, 95%CI 2.45-22.73). CONCLUSION:Patient incentives can increase adherence to DOT in TB programs.
Authors: Evan S Herrmann; Alexis K Matusiewicz; Maxine L Stitzer; Stephen T Higgins; Stacey C Sigmon; Sarah H Heil Journal: J Subst Abuse Treat Date: 2016-06-24
Authors: Melbourne F Hovell; Carol L Sipan; Elaine J Blumberg; C Richard Hofstetter; Donald Slymen; Lawrence Friedman; Kathleen Moser; Norma J Kelley; Alicia Y Vera Journal: Am J Public Health Date: 2003-11 Impact factor: 9.308
Authors: Charles S Wiysonge; Elizabeth Paulsen; Simon Lewin; Agustín Ciapponi; Cristian A Herrera; Newton Opiyo; Tomas Pantoja; Gabriel Rada; Andrew D Oxman Journal: Cochrane Database Syst Rev Date: 2017-09-11
Authors: Tom Wingfield; Marco A Tovar; Doug Huff; Delia Boccia; Matthew J Saunders; Sumona Datta; Rosario Montoya; Eric Ramos; James J Lewis; Robert H Gilman; Carlton Evans Journal: Clin Med (Lond) Date: 2016-12 Impact factor: 2.659